Anti-Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Monoclonal Antibody

FH3; HCHOLA3; NARC1; Hypercholesterolemia,Autosomal Dominant 3; Neural apoptosis-regulated convertase 1; Proprotein convertase 9; Subtilisin/kexin-like protease PC9

USAGE

Flow cytometry: 10µg/ml;
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Biological Trace Element Research Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers pubmed:28409410
BASIC RESEARCH IN CARDIOLOGY Autocrine effects of PCSK9 on cardiomyocytes Pubmed: 33169229
J Transl Med Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans 33407555
Metabolism MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice 33775647
Eur Rev Med Pharmacol Sci Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders 34533801
Clin Exp Hypertens Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease Pubmed:35502687